ATE111532T1 - Test für lösliche quervernetzte fibrinpolymere. - Google Patents
Test für lösliche quervernetzte fibrinpolymere.Info
- Publication number
- ATE111532T1 ATE111532T1 AT89111471T AT89111471T ATE111532T1 AT E111532 T1 ATE111532 T1 AT E111532T1 AT 89111471 T AT89111471 T AT 89111471T AT 89111471 T AT89111471 T AT 89111471T AT E111532 T1 ATE111532 T1 AT E111532T1
- Authority
- AT
- Austria
- Prior art keywords
- dimer
- fibrin polymers
- soluble
- test
- assay
- Prior art date
Links
- 108010073385 Fibrin Proteins 0.000 title abstract 5
- 102000009123 Fibrin Human genes 0.000 title abstract 5
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 title abstract 5
- 229950003499 fibrin Drugs 0.000 title abstract 5
- 229920000642 polymer Polymers 0.000 title abstract 4
- 239000003154 D dimer Substances 0.000 abstract 4
- 108010052295 fibrin fragment D Proteins 0.000 abstract 4
- 208000007536 Thrombosis Diseases 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 206010051055 Deep vein thrombosis Diseases 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 208000010378 Pulmonary Embolism Diseases 0.000 abstract 1
- 206010047249 Venous thrombosis Diseases 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000013610 patient sample Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 201000005665 thrombophilia Diseases 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/972—Plasminogen activators
- G01N2333/9726—Tissue plasminogen activator
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Multicomponent Fibers (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21357288A | 1988-06-24 | 1988-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE111532T1 true ATE111532T1 (de) | 1994-09-15 |
Family
ID=22795625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89111471T ATE111532T1 (de) | 1988-06-24 | 1989-06-23 | Test für lösliche quervernetzte fibrinpolymere. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0347933B1 (de) |
| JP (1) | JP2657417B2 (de) |
| AT (1) | ATE111532T1 (de) |
| DE (1) | DE68918170T2 (de) |
| DK (1) | DK313889A (de) |
| ES (1) | ES2060698T3 (de) |
| IE (1) | IE67430B1 (de) |
| PT (1) | PT90941B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453359A (en) * | 1988-06-13 | 1995-09-26 | American Biogenetic Sciences, Inc. | Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
| FR2703788B1 (fr) * | 1993-04-09 | 1996-12-20 | Jacques Toledano | Dispositif et procede anti-idiotype de detection immunologique. |
| SE9403833D0 (sv) * | 1994-11-08 | 1994-11-08 | Global Hemostasis Inst Mgr Ab | Analysförfarande och kit |
| FR2813395B1 (fr) * | 2000-08-28 | 2003-01-24 | Stago Diagnostica | Methode de dosage in vitro de la fibrine soluble par generation de produits de degradation specifiques |
| MXPA03012030A (es) | 2001-06-26 | 2005-07-01 | Agen Biomedical Ltd | Anticuerpos humanizados derivados de dd-3b6/22, especificos para el fragmento de dimero d de fibrina. |
| DE10247876A1 (de) * | 2002-10-14 | 2004-05-13 | Aventis Behring Gmbh Intellectual Property/Legal | Verfahren zur Bestimmung von Multimeren von Plasmaproteinen |
| WO2006118195A1 (ja) | 2005-04-28 | 2006-11-09 | Mitsubishi Kagaku Iatron, Inc. | 安定化フィブリンのプラスミン分解物の免疫学的分析方法 |
| FR2900734B1 (fr) * | 2006-05-05 | 2009-03-06 | Diagnostica Stago Soc Par Acti | Detection des maladies veineuses thromboemboliques par le dosage des d-dimeres et de la fibrine soluble |
| CN110007094B (zh) * | 2019-04-29 | 2022-04-05 | 江苏众红生物工程创药研究院有限公司 | 人d-二聚体定量检测卡及其临床应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU572125B2 (en) * | 1983-03-17 | 1988-05-05 | Mabco Limited | Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses |
| DE3430906A1 (de) * | 1984-08-22 | 1986-02-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung von fibrinmonomer in plasma |
| AU7912887A (en) * | 1986-08-25 | 1988-03-24 | American Biogenetic Sciences, Inc. | Monoclonal antibodies to fibrin |
-
1989
- 1989-06-21 IE IE201089A patent/IE67430B1/en not_active IP Right Cessation
- 1989-06-22 PT PT90941A patent/PT90941B/pt not_active IP Right Cessation
- 1989-06-23 DE DE68918170T patent/DE68918170T2/de not_active Expired - Fee Related
- 1989-06-23 EP EP89111471A patent/EP0347933B1/de not_active Expired - Lifetime
- 1989-06-23 AT AT89111471T patent/ATE111532T1/de not_active IP Right Cessation
- 1989-06-23 DK DK313889A patent/DK313889A/da not_active Application Discontinuation
- 1989-06-23 JP JP1159825A patent/JP2657417B2/ja not_active Expired - Lifetime
- 1989-06-23 ES ES89111471T patent/ES2060698T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2060698T3 (es) | 1994-12-01 |
| DE68918170T2 (de) | 1995-03-02 |
| DK313889A (da) | 1989-12-25 |
| PT90941B (pt) | 1994-11-30 |
| EP0347933B1 (de) | 1994-09-14 |
| JPH02112763A (ja) | 1990-04-25 |
| IE892010L (en) | 1989-12-24 |
| IE67430B1 (en) | 1996-04-03 |
| PT90941A (pt) | 1989-12-29 |
| JP2657417B2 (ja) | 1997-09-24 |
| DE68918170D1 (de) | 1994-10-20 |
| EP0347933A2 (de) | 1989-12-27 |
| DK313889D0 (da) | 1989-06-23 |
| EP0347933A3 (en) | 1990-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Urano et al. | Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1 | |
| Dale et al. | Comparison of three D-dimer assays for the diagnosis of DVT: ELISA, latex and an immunofiltration assay (NycoCard D-Dimer) | |
| Darvall et al. | Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls | |
| DK0623213T3 (da) | Instrument og fremgangsmåde til bestemmelse af koagulatelasticitetsmodul, styrkeudvikling og erythrocytfleksibilitet under | |
| ATE111532T1 (de) | Test für lösliche quervernetzte fibrinpolymere. | |
| Blann et al. | von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis | |
| Mannucci et al. | Detection of the prethrombotic state due to procoagulant imbalance | |
| Roussi et al. | Contribution of D-Dimer determination in the exclusion of deep venous thrombosis in spinal cord injury patients | |
| Sturk et al. | Analytical and clinical evaluation of commercial protein C assays | |
| Fligelstone et al. | Lupus anticoagulant in patients with peripheral vascular disease: a prospective study | |
| DK386388A (da) | Antistof til propeptidet for procollagen type iii og proevemetode under anvendelse deraf | |
| Borg et al. | Rapid quantitative D-dimer assay and clinical evaluation for the diagnosis of clinically suspected deep vein thrombosis | |
| Rowe et al. | Rapid detection of D-dimer using a fiber optic biosensor | |
| Palareti | Fibrinogen/fibrin degradation products: Pathophysiology and clinical application | |
| SU786991A1 (ru) | Способ диагностики хронического простатита | |
| NO159755C (no) | Fremgangsm te for bestemmelse av allergisk foelsomhe | |
| Kirchhof et al. | Early detection of DIC by screening methods | |
| Holtkötter et al. | Determination of fibrin monomers in pathological plasma samples | |
| SU995747A1 (ru) | Способ диагностики хронического простатита | |
| SU1105189A1 (ru) | Способ диагностики атопии | |
| SU949403A1 (ru) | Способ определени триботехнических характеристик кинематических пар | |
| Heit et al. | Plasma D-dimer levels and diagnosis of pulmonary embolism | |
| Sidelmann et al. | A spectroscopic microtiter fibrin plate assay | |
| Sasaki et al. | An experimental model of in vivo fibrinolysis | |
| Kuhnt et al. | Influence of venous occlusion on the results of an activated microtitre clot lysis assay in plasma from individuals with and without a history of venous thrombosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |